These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22103836)

  • 1. The CD4C/HIV(Nef)transgenic model of AIDS.
    Jolicoeur P
    Curr HIV Res; 2011 Oct; 9(7):524-30. PubMed ID: 22103836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult AIDS-like disease in a novel inducible human immunodeficiency virus type 1 Nef transgenic mouse model: CD4+ T-cell activation is Nef dependent and can occur in the absence of lymphophenia.
    Rahim MM; Chrobak P; Hu C; Hanna Z; Jolicoeur P
    J Virol; 2009 Nov; 83(22):11830-46. PubMed ID: 19740990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
    Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
    J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease.
    Weng X; Priceputu E; Chrobak P; Poudrier J; Kay DG; Hanna Z; Mak TW; Jolicoeur P
    J Virol; 2004 May; 78(10):5244-57. PubMed ID: 15113906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.
    Priceputu E; Hanna Z; Hu C; Simard MC; Vincent P; Wildum S; Schindler M; Kirchhoff F; Jolicoeur P
    J Virol; 2007 May; 81(9):4677-93. PubMed ID: 17314161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease.
    Simard MC; Chrobak P; Kay DG; Hanna Z; Jothy S; Jolicoeur P
    J Virol; 2002 Apr; 76(8):3981-95. PubMed ID: 11907238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective expression of human immunodeficiency virus Nef in specific immune cell populations of transgenic mice is associated with distinct AIDS-like phenotypes.
    Hanna Z; Priceputu E; Chrobak P; Hu C; Dugas V; Goupil M; Marquis M; de Repentigny L; Jolicoeur P
    J Virol; 2009 Oct; 83(19):9743-58. PubMed ID: 19605470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal development and function but impaired memory phenotype of CD8⁺ T cells in transgenic mice expressing HIV-1 Nef in its natural target cells.
    Ahmed Rahim MM; Chrobak P; Priceputu E; Hanna Z; Jolicoeur P
    Virology; 2013 Apr; 438(2):84-97. PubMed ID: 23433958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AIDS disease of CD4C/HIV transgenic mice shows impaired germinal centers and autoantibodies and develops in the absence of IFN-gamma and IL-6.
    Poudrier J; Weng X; Kay DG; Paré G; Calvo EL; Hanna Z; Kosco-Vilbois MH; Jolicoeur P
    Immunity; 2001 Aug; 15(2):173-85. PubMed ID: 11520454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of p21-activated kinase 2 and its association with Nef are conserved in murine cells but are not sufficient to induce an AIDS-like disease in CD4C/HIV transgenic mice.
    Vincent P; Priceputu E; Kay D; Saksela K; Jolicoeur P; Hanna Z
    J Biol Chem; 2006 Mar; 281(11):6940-54. PubMed ID: 16407193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Linking Nef with the immunological and virological determinants of AIDS].
    Gómez-Icazbalceta G; Larralde C
    Rev Invest Clin; 2009; 61(3):243-51. PubMed ID: 19736813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Nef expression favors the relative preservation of CD4+ T regulatory cells that retain some important suppressive functions.
    Chrobak P; Afkhami S; Priceputu E; Poudrier J; Meunier C; Hanna Z; Sparwasser T; Jolicoeur P
    J Immunol; 2014 Feb; 192(4):1681-92. PubMed ID: 24465014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Nef mutations abrogating downregulation of CD4 affect other Nef functions and show reduced pathogenicity in transgenic mice.
    Hanna Z; Priceputu E; Hu C; Vincent P; Jolicoeur P
    Virology; 2006 Mar; 346(1):40-52. PubMed ID: 16310238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/HIV transgenic mice.
    Hanna Z; Priceputu E; Kay DG; Poudrier J; Chrobak P; Jolicoeur P
    Virology; 2004 Oct; 327(2):273-86. PubMed ID: 15351215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Nef disrupts maturation of CD4+ T cells through CD4/Lck modulation.
    Chrobak P; Simard MC; Bouchard N; Ndolo TM; Guertin J; Hanna Z; Dave V; Jolicoeur P
    J Immunol; 2010 Oct; 185(7):3948-59. PubMed ID: 20826747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice.
    Hanna Z; Kay DG; Rebai N; Guimond A; Jothy S; Jolicoeur P
    Cell; 1998 Oct; 95(2):163-75. PubMed ID: 9790524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth failure and AIDS-like cachexia syndrome in HIV-1 transgenic mice.
    Santoro TJ; Bryant JL; Pellicoro J; Klotman ME; Kopp JB; Bruggeman LA; Franks RR; Notkins AL; Klotman PE
    Virology; 1994 May; 201(1):147-51. PubMed ID: 7909972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck.
    Hanna Z; Weng X; Kay DG; Poudrier J; Lowell C; Jolicoeur P
    J Virol; 2001 Oct; 75(19):9378-92. PubMed ID: 11533201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene.
    Goupil M; Trudelle EB; Dugas V; Racicot-Bergeron C; Aumont F; Sénéchal S; Hanna Z; Jolicoeur P; de Repentigny L
    Infect Immun; 2009 Sep; 77(9):4136-49. PubMed ID: 19564379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1.
    Marquis M; Lewandowski D; Dugas V; Aumont F; Sénéchal S; Jolicoeur P; Hanna Z; de Repentigny L
    Infect Immun; 2006 Apr; 74(4):2382-91. PubMed ID: 16552068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.